Effect of estrogen and angiotensin-converting enzyme inhibitor on vascular remodeling in ovariectomized spontaneously hypertensive rats

Menopause

Volumn 13, Issue 3, 2006, Pages 397-403

  García, Maria P ^a   Giménez, Jose ^a   Serna, Mar ^a   Salom, Miguel G ^a   Bonacasa, Bárbara ^a   Carbonell, Luis F ^a   Quesada, Tomas ^a   Hernández, Isabel ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

ACE inhibition; Estrogen; Hypertension; Ovariectomy; Vascular remodeling

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTRADIOL; ESTROGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; HEART PROTECTION; HYPERTENSION; IMMUNOBLOTTING; NONHUMAN; OVARIECTOMY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HYPERTENSION; OVARIECTOMY; RATS; RATS, INBRED SHR; VASCULAR RESISTANCE; VASODILATION;

EID: 33745235794     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000222472.08593.e4     Document Type: Article

References (29)

1. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II). JAMA 2002;288:49-57.
2. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-613.
3. Hodis HN, Mack WJ, Azen SP, Lobo RA, Soupe D, Mahrer PR, et al. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 2003;349:535-545.
4. Rossouw J. Effect of postmenopausal hormone therapy on cardiovascular risk. J Hypertens 2002;20:S62-S65.
5. Heagerty AM, Aalkjaer C, Bund ST, Kosgaard N, Mulvany MJ. Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension 1993;21:931-937.
6. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension. Roles of apoptosis, inflammation and fibrosis. Hypertension 2001;38:581-587.
7. Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension 1998;31:152-161.
8. Touyz RM, Tabet F, Schiffrin EL. Redox-dependent signaling by angiotensin II and vascular remodeling in hypertension. Clin Exp Pharmacol Physiol 2003;30:860-866.
9. Touyz RM. The role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 2003;5:155-164.
10. Touyz RM, He G, El Mabrouk M, Diep Q, Mardigyan V, Schiffrin EL. Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats. J Hypertens 2001;19:553-559.
11. Jiménez J, Garcia MP, Serna M, Quesada T, Carbonell LF, Hernández I. Estrogens reduce myocardial arterial remodeling and vascular mitogen-activated protein kinase expression in female spontaneously hypertensive rats. J Hypertens 2004;21:S185.
12. Nigro D, Fortes ZB, Scivoletto R, Barbeiro HV, Carvalho MH. Sex-related differences in the response of spontaneously hypertensive rats to angiotensin-converting enzyme inhibitor. Endothelium 1997;5:63-71.
13. Silva-Antonialli MM, Fortes ZB, Carvalho MH, Scivoletto R, Nigro D. Sexual dimorphism in the response of thoracic aorta from SHRs to losartan. Gen Pharmacol 2000;34:329-335.
14. Preston RA, Alonso A, Panzitta D, Zhang P, Karara AH. Additive effect of drospirenone/17-beta-estradiol in hypertensive postmenopausal women receiving enalapril. Am J Hypertens 2002;5:816-822.
15. Safar ME, Myers MG, Leenen F, Asmar R. Gender influence on the dose-ranging of a low-dose perindopril-indapamide combination in hypertension: effect on systolic and pulse pressure. J Hypertens 2002;20:1653-1661.
16. Tostes RC, Nigro D, Fortes ZB, Carvalho MH. Effects of estrogen on the vascular system. Braz J Med Biol Res 2003;36:1143-1158.
17. Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004;109:672-693.
18. Hernández I, Delgado JL, Díaz J, et al. 17β-Estradiol prevents oxidative stress and decreases blood pressure in ovariectomized rats. Am J Physiol Regul Meg Comp Physiol 2000;279:R1599-R1605.
19. Intengan HD, Thibault G, Li JS, Schiffrin EL. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 1999;100:2267-2275.
20. Gordi T, Khamis H. Simple solution to a common statistical problem: interpreting multiple range tests. Clin Ther 2004;26:780-786.
21. Pelzer T, de Jager T, Muck J, Stimpel M, Neyses L. Oestrogen action on the myocardium in vivo: specific and permissive for angiotensin-converting enzyme inhibition. J Hypertens 2002;20:1001-1006.
22. Schiffrin EL. Reactivity of small blood vessels in hypertension: relationship with structural changes. Hypertension 1992;19:1-9.
23. Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res 2002;53:688-708.
24. Mendelsohn ME, Karas RH. The protective effect of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.
25. Dubey RK, Jackson EK. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am J Physiol Renal Physiol 2001;280:F365-F388.
26. Proudler AJ, Ahmed AI, Crook D, et al. Hormone replacement therapy and serum angiotensin-converting enzyme activity in postmenopausal women. Lancet 1995;346:89-90.
27. Gallagher PE, Li P, Lenhart JR, Chappell MC, Broshihan KB. Estrogen regulation of angiotensin-converting enzyme Mrna. Hypertension 1999;33:323-328.
28. 1 receptor blocker on neointima formation. Hypertension 2002;40:451-457.
29. Takeda-Matsubara Y, Nakagami H, Iwai M, et al. Estrogen activates phosphatases and antagonizes growth-promoting effects of angiotensin II. Hypertension 2002;39:41-45.